The effect of furosemide on gentamicin excretion and tissue accumulation was studied with clearance techniques in anesthetized rats, at two different infusion rates of saline or Ringer solution. Gentamicin (-20 ). An infusion of the same solution at 1.2 ml/h immediately followed and was continued for 3 h. Collection of blood and urine samples began 1 h after priming dose and consisted of four consecutive clearance periods of 30 min each. At the end of each experiment, the kidneys were excised and divided into cortex and medulla for tiasue analysis of gentamicin.
The effect of furosemide on gentamicin excretion and tissue accumulation was studied with clearance techniques in anesthetized rats, at two different infusion rates of saline or Ringer solution. Gentamicin (-20 mg/kg) was administered by constant intravenous infusion over a period of 3 h. With the low fluid infusion rate, furosemide (25 mg/kg intravenously) caused severe reduction in glomerular filtration rate and diminished urinary output of gentamicin. Serum and renal tissue levels of the antibiotic were significantly elevated. High fluid infusion prevented the decline of the glomerular filtration rate, with near normalization of all measurements. A fluid deficit incurred by furosemide was noted at both the low and high infusion rates. Complete correction of this fluid deficit by continuous adjustment of the infusion rate fully restored normal renal handling of gentamicin. These results suggest that furosemide had no direct effect on renal excretion of gentamicin. In comparison, renal handling of gentamicin in rats did not respond to changes in the rate of fluid infusion in the absence of furosemide therapy. It appears that gentamicin excretion and gentamicin accumulation in the renal cortex in furosemide-treated rats, in contrast with those in untreated rats, are influenced significantly by the rate offluid infusion. Fluid administration sufficient to maintain the glomerular filtration rate was found to be necessary for appropriate gentamicin elimination, with consequent reduction in serum and renal tissue levels of the drug.
Concentrations of gentamicin in the renal cortex and medulla were not altered by hydration in dogs (11) . The present work was undertaken to ascertain whether potent loop diuretics such as furosemide have a "washout" effect and prevent gentamicin from depositing in the renal parenchyma. Since furosemide could cause renal dysfunction by severe depletion of body fluid and electrolytes (4, 6, 9) ). An infusion of the same solution at 1.2 ml/h immediately followed and was continued for 3 h. Collection of blood and urine samples began 1 h after priming dose and consisted of four consecutive clearance periods of 30 min each. At the end of each experiment, the kidneys were excised and divided into cortex and medulla for tiasue analysis of gentamicin.
(ii) High fluid infusion rate. Saline (four rats) or
Ringer solution (two rats), at a rate of 6.3 ml/h, was infused for 1 h preceding the administration of inulin and gentamicin as described in (i) and continued for 3 h thereafter.
(iii) Low fluid infusion rate plus furosemide.
A 4-h infusion of Ringer solution, 1.2 ml/h, containing furosemide (priming dose, 5 mg/kg; sustaining dose, 5 mg/kg per h), was started 1 h before the administration of inulin as in (i) in each of six rats with and without gentamicin.
(iv) High fluid infusion rate plus furosemide. of gentamicin, no significant differences were t 3 e noted between the low and high infusion groups. In addition, the drug contents in the renal cortex°a nd medulla were similar in the two groups despite a great discrepancy in fluid infusion. (Table  00  2 ). This was due to the fact that the latter also + ;: o°e xcreted more urine while receiving more fluid c3-o o than the former. In the absence of gentamicin, the mean GFRs (in milliliters per minute per 100 g of body weight) were 0.34 ± 0.05 (n = 4) for the low infusion group and 0.55 ± 0.04 (n = 5) for the high infusion group, respectively, durx H V ing furosemide therapy. Similar values for GFR V were observed in corresponding groups that rea oq ceived a constant infusion of gentamicin (Table  2) . Thus, under the present experimental conditions, gentamicin did not exert adverse effects z e on kidney function in the presence of furosemide.
The steady-state serum levels of gentamicin were markedly elevated in the low infusion group (Table 2 ). In addition, a striking rise in gentamicin concentration in the renal cortex and (Table 1 ).
In comparison with the low infusion group, the use of fluid infusion at high rates effectively lowered drug levels in the renal tissues (Table  2 ). Excretion and steady-state serum levels of gentamicin were ameliorated, accompanying an increase in GFR.
Accurate replacement of fluid losses further improved GFR as well as gentamicin eliminated in the urine when compared with the high infusion group that suffered fluid deficit despite high fluid intake ( Table 2 ). Values of these measurements and the associated steady-state serum levels of gentamicin were not different from those obtained in the absence of furosemide therapy (Table 1) . Coincidental with extraordinarily high urine flow, there was an appreciable reduction in the medullary content of gentamicin, while the cortical gentamicin remained in the normal ranges. DISCUSSION The present data demonstrated that, in the absence of furosemide, gentamicin levels in the serum and renal tissues are relatively unaffected by changes in fluid infusion. Slight increases in GFR during high fluid infusion did not augment urinary excretion of the drug appreciably. Our findings were consistent with a recent report that the state of hydration in normal dogs does not influence intrarenal distribution of gentamicin (11) . In contrast with untreated rats, GFR in the furosemide-treated animals was highly susceptible to changes in rate of fluid infusion.
GFR was rendered less than half of normal by furosemide when fluid infusion was low and was considerably improved with increased infusion. Simultaneously, the elevated serum levels, diminished excretion, and increased accumulation of gentamicin in the kidney in association with low fluid infusion were ameliorated by high fluid infusion during furosemide.
As in dogs (1), GFR in rats would not be affected by furosemide if fluid deficit were prevented by continuous replacement for urinary losses. Nevertheless, under conditions where fluid correction was incomplete, suppression of GFR by furosemide was more marked in animals receiving low infusion than those with high infusion despite the similar net fluid deficit in both groups at the end of experiments. Therefore, fluid depletion alone did not seem to account for the fall in GFR (6) . Clearance measurements (2) (7, 8, 10) . Auming that zero plam protein binding of gentamicin, as previously reported (3), occurred under the conditions of our experiments, the filtered load of gentamicin was reduced in the frosemide-treated rats receiving low fluid insion (Table 2) . Nevertheless, the cortical uptake of the drug in these animals was higher than in all other groups, suggesting enhanced reabsorption in association with diminished GFR.
Accurate correction of fluid deficit during furosemide treatment ensures complete normalization of urinary output of gentamicin by restoration of GFR. In addition, with or without full volume repletion, cortical uptake of gentamicin was normal in the presence of furosemide if fluid intake was high. Therefore, it is clear that furosemide itself has no direct influence on the urinary excretion and cortical accumulation of gentamicin. Reduced medullary concentration when urine flow is inordinately high seems to demonstrate decreased passive diffusion of the drug in the distal nephron. Since gentamicin is highly hydrophilic, passive movement in the medullary region must be limited and is undetectable in most circumstances (Table 1) .
The excretion and tissue levels of gentamicin seem most affected by changes of filtration rate.
The filtration rate in tum depends on rate of fluid replacement, especially during acute volume contraction as a result of concurrent use of potent natriuretic agents such as furosemide. It is concluded that furosemide, in the absence of volume repletion adequate to maintain renal function, may cause accumulation of aminoglycosides, and that furosemide does not appear to have a direct effect on renal handling of gentazmcm.
